KEZAR LIFE SCIENCES
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders. In parallel with this work, Christopher and Kezar co-founder Jack Taunton, Ph.D. collaborated on several research projects involving protein secretion. This collaboration inspired a belief in the strong synergies between protein degradation and protein secretion, two fertile areas for drug discovery with platform potential.
KEZAR LIFE SCIENCES
Industry:
Health Care Health Diagnostics Life Science Therapeutics
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.kezarlifesciences.com
Total Employee:
11+
Status:
Active
Contact:
(650)822-5600
Email Addresses:
[email protected]
Total Funding:
123 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator Comcast KnowBe4 DocuSign
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Kezar Life Sciences
Solasta Ventures
Solasta Ventures investment in Post-IPO Equity - Kezar Life Sciences
Omega Funds
Omega Funds investment in Series B - Kezar Life Sciences
Pappas Ventures
Pappas Ventures investment in Series B - Kezar Life Sciences
Bay City Capital
Bay City Capital investment in Series B - Kezar Life Sciences
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Kezar Life Sciences
Cowen Group
Cowen Group investment in Series B - Kezar Life Sciences
Morningside Group
Morningside Group investment in Series B - Kezar Life Sciences
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Kezar Life Sciences
Chiesi Ventures
Chiesi Ventures investment in Series B - Kezar Life Sciences
Key Employee Changes
Official Site Inspections
http://www.kezarlifesciences.com Semrush global rank: 8.23 M Semrush visits lastest month: 349
Unable to get host informations!!!
More informations about "Kezar Life Sciences"
Our Company - Kezar Life Sciences Inc.
Apr 21, 2022 At Kezar Life Sciences, we are developing first-in-class, small molecule therapies designed to inhibit multiple โฆSee details»
Executive Team - Kezar Life Sciences Inc.
Jun 2, 2022 Before joining Kezar Life Sciences, Joe held significant roles at Assembly Biosciences, AbbVie, Amgen, and Genentech. He earned his Bachelorโs in Interpersonal & โฆSee details»
Kezar Life Sciences - Establishing new paths for treating chronic โฆ
Proteins are essential to every cell in the body and when dysregulated, can play a role in activating disease-driving cellular pathways. Utilizing the teamโs deep scientific expertise, โฆSee details»
Kezar Life Sciences - Crunchbase Company Profile
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders. In parallel with โฆSee details»
Kezar Life Sciences - LinkedIn
Kezar Life Sciences Biotechnology Research South San Francisco, California 5,149 followers Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disordersSee details»
Kezar Life Sciences, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kezar Life Sciences, Inc. of South San Francisco, CA. Get the latest business insights from Dun & โฆSee details»
Kezar Life Sciences Company Profile | Management and ... - Datanyze
Www.kezarlifesciences.com Kezar Life Sciences Profile and History Kezar Life Sciences is a clinical-stage biopharmaceutical company discovering and developing breakthrough โฆSee details»
Kezar Life Sciences - Overview, News & Similar companies
Apr 8, 2024 Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar โฆSee details»
Investors & Media - Kezar Life Sciences, Inc.
The Investor Relations website contains information about Kezar Life Sciences, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Kezar Life Sciences - Craft
Kezar Life Sciences has 1 employees at their 1 location and $7 m in annual revenue in FY 2023. See insights on Kezar Life Sciences including office locations, competitors, revenue, โฆSee details»
Kezar Life Sciences Inc Company Profile - Overview - GlobalData
Website kezarlifesciences.com Telephone 1 650 8225600. No of Employees 58. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange KZR (NASD) Revenue (2023) โฆSee details»
Contact Us - Kezar Life Sciences Inc.
Corporate Headquarters. 4000 Shoreline Court Suite 300 South San Francisco, CA 94080See details»
Kezar Life Sciences Company Profile: Overview and Full News โฆ
Kezarlifesciences.com. Overview: Kezar Life Sciences. Kezar Life Sciences, based in California, is a company focused on establishing new paths for treating chronic diseases through innovative โฆSee details»
Kezar Life Sciences - VentureRadar
Website: http://www.kezarlifesciences.com/ Develops breakthrough treatments for immune-mediated and oncologic disorders by pioneering first-in-class, small molecule ...See details»
Kezar Life Sciences - Golden
Kezar Life Sciences is a biotechnology company focused on the discovery and development of breakthrough treatments for immune-mediated and oncologic disorders.See details»
Kezar Life Sciences (KZR) Company Profile & Description - Stock โฆ
Jun 21, 2018 Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in โฆSee details»
Kezar Life Sciences - workinbiotech.com
Kezar Life Sciences is developing protein-targeting small molecule therapeutics to treat autoimmune diseases. Proteins are essential for cells to function and unsurprisingly, their โฆSee details»
Press Release Details - Kezar Life Sciences, Inc.
May 1, 2018 In addition, Kezar is also leveraging its protein secretion pathway platform to discover and develop small molecule therapies targeting cancer and immuno-oncology. For โฆSee details»
Kezar Life Sciences, Inc. (Kezar Life Sciences, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
Zetomipzomib (KZR-616) is a selective inhibitor of the immunoproteasome currently undergoing clinical investigation in autoimmune disorders. Here, we characterized KZR-616 in vitro and in โฆSee details»
Our Pipeline - Kezar Life Sciences Inc.
4000 Shoreline Court Suite 300 South San Francisco, CA 94080. [email protected] (650) 822-5600. Visit us on LinkedInSee details»